The largest database of trusted experimental protocols

7 protocols using armenian hamster igg

1

Immune Modulation for Retinal Protection

Check if the same lab product or an alternative is used in the 5 most similar protocols
I) For CD4+ T cell depletion, intraperitoneal injection of Ultra-LEAF™ Purified anti-mouse CD4 Antibody (10 μg/g, clone GK1.5, BioLegend, San Diego, CA, USA) or corresponding isotype antibody (Ultra-LEAF Purified Rat IgG2b, κ Isotype Ctrl Antibody, clone RTK4530, 10 μg/g, BioLegend) was performed in mice on day 15, 25, and 40 PMI. ii) For CXCR3 blockade, intraperitoneal injection of Ultra-LEAF™ Purified anti-mouse CD183 (CXCR3) Antibody (10 μg/g, clone CXCR3-173, BioLegend) or corresponding isotype antibody (Armenian Hamster IgG, clone: HTK888, BioLegend) was performed in mice every 7 days since day 15 PMI. iii) For systemic IFN-g blocking, mice were injected i.p. with 200 mg of anti-IFN-g antibody (InVivoMAb anti-mouse IFNγ, BioXcell, clone XMG1.2) every 3 days since day 15 PMI. An IgG1 isotype antibody (HRPN, BioXcell) was used to serve as control. iv) To block VCAM-1, a InVivoMAb anti-mouse VCAM-1 (10 mg/kg, BioXcell; corresponding isotype antibody: InVivoMAb rat IgG1 isotype control, clone HRPN, BioXcell) was administrated intravenously in MB-injected mice every 3 days since day 15 PMI. For retinal evaluation in abovementioned in vivo antibody intervention experiments, one retina from each recipient mouse was randomly selected and used for RGC density, while the other was for Iba1 and GFAP staining.
+ Open protocol
+ Expand
2

Modulation of Cardiomyocyte Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
In some experiments, cardiomyocytes were preincubated for 30 min with different pharmacological inhibitors: L-NAME (100 µM, NOS inhibitor), 1H-[1.2.4]oxadiazolo[4.3-a]quinoxalin-1-one [ODQ, 25 µM, soluble guanylate cyclase (sGC) inhibitor], 6,7-dimethyl-3-[(methyl{2-[methyl({1-[3-(trifluoromethyl)phenyl]-1H-indol-3-yl}methyl)amino]ethyl}amino)methyl]-4H-chromen-4-one,-diHCl (SPD 304, 10 µM, TNF-inhibitor, Calbiochem, Darmstadt, Germany). A specific antibody to TNFR1 (purified anti-mouse TNFR type 1/p55, 20 µg/mL, BioLegend, San Diego, CA), a leaf purified Armenian hamster IgG (20 µg/mL, BioLegend) or TNF-α (50 ng/mL, Miltenyi Biotec, Bisley, UK) were also used. All drugs were prepared as a stock solution in appropriate solvents. All the drugs were used at already reported maximally active concentrations. On the day of the experiment, stock solutions were diluted to the desired concentration and the final concentration of DMSO was <0.1%. For the treatment with MPs (4 h) of cardiomyocytes further used in western blot, M199 culture medium was supplemented with creatine (5 mM), carnitine (5 mM), taurine (5 mM), HEPES (25 mM) and penicillin/streptomycin (1%). Unless stated, all chemicals were obtained from Sigma-Aldrich (St. Louis, MO).
+ Open protocol
+ Expand
3

Flow Cytometry Analysis of T Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Agonist anti-DR3 (4C12) and TL1A.Ig were previously described (8 (link), 11 (link)). Armenian Hamster IgG was purchased from Biolegend. Antibodies used for flow cytometry were: PE-conjugated anti-Gal-9 (108A2), pacific blue-conjugated anti-CD3 (145-2C11) and anti-CD4 (GK1.5), and PE-conjugated anti-Siglec-F (E5-2440), all from BD Biosciences, and PE-conjugated anti-DR3 from Biolegend. In some cases, cells were preincubated with anti-mouse CD16/CD32 (2.4G2; 10 μg/ml) to block FcγR and stained with pacific blue anti-CD4, fixed with Cytofix/Cytoperm (BD Biosciences), and then stained with PerCP-Cy5.5 anti-IL-17A, PE-Cy7 anti-IFN-γ, PE-Cy7 anti-TNF, PE anti-IL-10, PerCP-Cy5.5 anti-Foxp3 (BD Biosciences) or Alexa Fluor anti-IDO (Biolegend). Samples were analyzed after gating on CD4+ T cells on a LSR-II flow cytometer (BD Biosciences) with FlowJo software (TreeStar).
+ Open protocol
+ Expand
4

Exosome Surface Marker Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies to CD9 (HI9a), CD63 (NVG-2), CD63 (H5C6), CD81 (Eat-2), CCR9 (9B1), CXCR4 (L276F12), and CX3CR1 (SA011F11) were purchased from BioLegend (San Diego, CA). Isotype controls including Rat IgG2a, Rat IgG2b, Armenian Hamster IgG, Mouse IgG2a, and Mouse IgG1 were also from BioLegend. The antibody to CD9 (KMC8) was obtained from BD Biosciences. The antibodies to CCR7 (4B12), CCR10 (248918) were acquired from R&D Systems. The cells or microbead-conjugated exosomes were stained with the fluorescently labeled antibodies, washed twice with PBS containing 2% FBS and 2 mM ethylenediaminetetraacetic acid (EDTA) (Wako, Osaka, Japan), and analyzed by using BD Accuri C6 flow cytometer and software (BD Biosciences). For this method of microbead conjugation of exosomes, only positive events can be detected and fluorescently quantified in the flow cytometry. In some experiments, total (intracellular plus surface) staining experiment was done by using FIX and PERM Kit (Thermo Fisher Scientific) according to manufacturer's instructions.
+ Open protocol
+ Expand
5

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell-surface and intracellular staining procedures were performed as previously described (31 (link)). Surfaces of 100 μl of cells (1×106) were stained using 10 μl fluorescein isothiocyanate-conjugated anti-CD25 and peridinin chlorophyll-conjugated anti-CD4 (eBiosciences, San Jose, CA, USA). Isotype control, mouse IgG1, was included in all the experiments. For intracellular staining, cells were saponized, washed in cold flow cytometry staining buffer and stained with phycoerythrin-conjugated anti-human Foxp3, its isotype control rat IgG2a (eBiosciences), Adenomatous polyposis coli anti-mouse/human Helios, and its isotype control Armenian Hamster IgG (BioLegend, Inc., San Diego, CA, USA). Flow cytometry was performed using FACSCanto II (BD Biosciences). Acquisition and analysis gates were restricted to the lymphocyte gate, as determined by their characteristic forward and side scatter properties. Flow data were analyzed using FlowJo software, version 7.6.5 (FlowJo, LLC, Ashland, OR, USA).
+ Open protocol
+ Expand
6

T cell activation by intestinal epithelial cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Carboxy fluorescein diacetate succinimidyl ester (CFSE) labelling was
performed as described (Koyama et al.,
2015
). In round-bottom 96-well plates, sort-purified CFSE-labeled
Marilynluc+ cells (CD90.1+) were stimulated with
sort-purified intestinal epithelial cells (IEC)
(CD326+CD45.2neg) from the small intestine of female
or male B6.WT mice which had undergone TBI 20h before, in the
presence of rhIL-2 (100 U/ml) (Zhang et al.,
2017
). Seven days later, Marilynluc+ T cells
(CD90.1+CD4+CD45.2+) were assessed for CFSE
dilution and expression of CD69 by flow cytometry. For CD80 blocking, purified
CD80 mAb (clone 16-10A1, BioLegend) or its isotype control (Armenian Hamster
IgG, BioLegend) was added to cultures at 1μg / ml.
+ Open protocol
+ Expand
7

Apoptosis Assay of Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
B16, MB49, and EL4 cells were seeded in a six-well plate until reaching ~90% of confluency in supplemented RPMI. Cells were treated with 1 and 10 ng/ml of anti-CD29 for 4 h. Armenian hamster IgG (Biolegend, San Diego, California, USA) was used as control. After 4 h, cells were collected and washed twice with cold PBS and then resuspended in 1× binding buffer (Biolegend, USA) at 106 cells/ml. One hundred microliters of the cell suspension was transferred onto a 5-ml culture tube. Five microliters of Annexin-v APC and 7-AAD was added per sample. The cells were gently vortexed and incubated for 20 min at room temperature. One hundred microliters of the binding buffer was added to each tube, and the samples were analyzed by fluorescence-activated cell sorting (FACS).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!